Swine Vaccines Market Size to Worth Around US$ 6.5 BN by 2030

According to Report, the global swine vaccines market size is expected to be worth around US$ 6.5 billion by 2030 from valued at US$ 2.45 billion in 2020 and growing at a CAGR of 5.9% from 2021 to 2030.

Increasing prevalence of diseases, a surge in the demand for animal protein, and growth in R&D expenditure for vaccines innovation are driving the market growth. Porcine Parvovirus (PPV), Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine circovirus type 2 (PCV2), Foot & Mouth Disease, Classical Swine Fever, and others remain to be extremely prevalent diseases in pig farms affecting economic losses.

Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39081

Swine production is a key component of global food security, agricultural countries, and local & international business. Contagious diseases impact pig health and stability and productivity of the swine industry globally. Thus, the rising prevalence of diseases in swine is estimated to drive the market over the forecast years. Porcine Parvovirus (PPV) is a reproductive disease present in most pig farms globally. Porcine Reproductive and Respiratory Syndrome (PRRS) remains to be a highly prevalent disease in pig farms affecting economic losses through its adverse effects on reproduction and growth as well as by clinical illness.

Report Coverage

By Product Analysis

The inactivated vaccines segment dominated the global market in 2020 with a revenue share of more than 38% in 2020. This is attributed to the easy availability, low cost, minimal risk of revert reaction of killed viruses, and new improvements by key players.

The recombinant vaccine segment is expected to exhibit the fastest CAGR from 2021 to 2028. These vaccines are anticipated to assist in achieving vaccination against several virus strains, as recombinants can carry numerous gene inserts.

By Type Analysis

The Porcine Circovirus type 2 (PCV2) dominated the global market with a revenue share of more than 14% in 2020. Transmission of PCV-2 may be by direct contact with an infected pig. PCV2 is the quickly mutating of all single-stranded DNA (ssDNA) viruses and thus, has a great mutation and recombination rate. 

The foot & mouth disease segment is expected to witness the second-fastest CAGR over the forecast period. In swine, foot-and-mouth disease is an epidemic that has a substantial effect on food safety and animal husbandry.

By Regional Analysis

Asia Pacific accounted for the maximum revenue share of more than 46% in 2020 and is anticipated to register the fastest CAGR during the forecast period. Middle-income nations, especially Southeast Asian countries, consume greater amounts of meat and the meat consumption of pork is still on the rise.

North America held a significant revenue share in 2020. The presence of well-established veterinary healthcare infrastructure, increased demand for animal protein, highly organized farming structure, and rising expenditure on animal health is attributed to the region’s growth. 

Key Players

• Merck Animal Health
• Ceva
• Zoetis
• Boehringer Ingelheim GmbH
• Elanco
• Indian Immunologicals Ltd.
• BiogénesisBagó
• Phibro Animal Health
• KM Biologics
• HIPRA

Market Segmentation

• By Type 
  • Swine Influenza
  • Classical Swine Fever
  • Porcine Parvovirus
  • Porcine Circovirus Type 2
  • M.Hyo
  • ActinobacillusPleuropneumonia
  • PRRS
  • Foot & Mouth Disease
  • Pseudorabies
  • PEDV
  • Others
• By Product 
  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
• By Region 
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Click Here to View Full Report Table of Contents

Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39081

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333